Loading data for UTMD — first visit, this takes a few seconds.

알림

Utah Medical Products Inc... (UTMD)

NasdaqGS: UTMD · 실시간 가격 · USD

72.00

+1.79 (2.55%)

종가 기준: Aug 18, 2026, 3:59 PM

2.55% (1D)

매수호가	51.27
시가총액	229.23M
매출 (ttm)	36.11M
순이익 (ttm)	10.49M
베타	0.36
EPS (ttm)	3.28
P/E (ttm)	21.43
선행 P/E	n/a
P/B (ttm)	1.90
P/S (ttm)	6.35
Earnings Date	Oct 22, 2026

매도호가	91.78
거래량	46,769
평균 거래량 (20일)	21,729
시가	70.80
전일 종가	70.21
일중 범위	70.80 - 72.45
52주 범위	53.66 - 75.75
애널리스트	n/a
목표주가	n/a
배당	$1.24 (1.77%)
배당락일	2026년 9월 17일

UTMD 소개

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PAL...

[더 보기]

산업 Medical Instruments & Supplies

섹터 Healthcare

IPO 일자 Mar 8, 1999

직원 수 140

상장 거래소 NasdaqGS

티커 UTMD

웹사이트 https://www.utahmed.com

전체 기업 정보

재무 실적

2025년 Utah Medical Products의 매출은 38.52M로, 전년 40.9M 대비 -5.83% 감소했습니다. 순이익은 11.29M로, -18.65% 감소했습니다.

재무제표

어닝 서프라이즈

Utah Medical Products가 Apr 24, 2014에 분기 실적을 발표했습니다:

매출 n/a 예상치 하회 $0, 및 -100.00% 전년 대비 감소.

EPS 0.72 예상치 하회 -0.07, 및 -1.37% 전년 대비 감소.

다음 실적 발표

Utah Medical Products Inc.의 실적 발표 예정일은 Oct 22, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

2주 전 · Zacks

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.

2개월 전 · Zacks

The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah

BRK.B, LLY and WMT headline top analyst reports, highlighting business strengths, growth drivers and key risks shaping their outlooks.

2개월 전 · Zacks

Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart

Berkshire Hathaway, Eli Lilly and Walmart headline new analyst reports, highlighting growth drivers, opportunities and key risks shaping their outlooks.

3개월 전 · Zacks

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.

4개월 전 · Zacks

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.

2 페이지 중 1

Utah Medical Products Inc... (UTMD)